Assessment of suberoylanilide hydroxamic acid on a Alzheimer's disease model induced by β-amyloid(1-42) in aged female mice: Neuromodulatory and epigenetic effect-Reference-Cited by-同舟云学术

Assessment of suberoylanilide hydroxamic acid on a Alzheimer's disease model induced by β-amyloid(1-42) in aged female mice: Neuromodulatory and epigenetic effect

Published:2023-04 Issue: Volume:375 Page:110429
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Athaide Rocha Kellen Mariane,Machado Franciele Romero,Poetini Márcia,Giacomeli Renata,Boeira Silvana Peterini,Jesse Cristiano Ricardo,Gomes de Gomes Marcelo^ORCID

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference52 articles.

1. Modifiable risk factors for incident dementia and cognitive impairment: an umbrella review of evidence;Zhang;J. Affect. Disord.,2022

2. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals;Petersen;JAMA,1995

3. Vaccinium uliginosum L. Improves amyloid β protein-induced learning and memory impairment in alzheimer's disease in mice;Choi;Prev. Nutr. Food Sci.,2014

4. Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling;Vitolo;Proc. Natl. Acad. Sci. U.S.A.,2002

5. [11C] Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer's disease;Pascoal;Nat. Commun.,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of histone deacetylases and their inhibitors in neurological diseases;Pharmacological Research;2024-09

2. A Comprehensive Review on Preclinical Alzheimer's Disease Models: Evaluating their Clinical Relevance;Current Pharmaceutical Biotechnology;2024-08-16

3. Prominent Perspective on Existing Biological Hallmarks of Alzheimer’s Disease;Current Topics in Medicinal Chemistry;2024-05

4. HDAC3 inhibition protects against peripheral and central alterations in an animal model of obesity;Pharmacological Reports;2023-09-12

5. Elaboration of the Effective Multi-Target Therapeutic Platform for the Treatment of Alzheimer’s Disease Based on Novel Monoterpene-Derived Hydroxamic Acids;International Journal of Molecular Sciences;2023-06-04